Author reply: To PMID 25001158

Affiliations

¹ Catholic University of Sacred Heart, Rome, Italy. Electronic address: dlepore@rm.unicatt.it.
² Catholic University of Sacred Heart, Rome, Italy.

Comment

Domenico Lepore et al. Ophthalmology. 2015 Aug.

. 2015 Aug;122(8):e49-50.

doi: 10.1016/j.ophtha.2015.02.018.

¹ Catholic University of Sacred Heart, Rome, Italy. Electronic address: dlepore@rm.unicatt.it.
² Catholic University of Sacred Heart, Rome, Italy.

No abstract available

Comment on

Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
Lepore D, Quinn GE, Molle F, Baldascino A, Orazi L, Sammartino M, Purcaro V, Giannantonio C, Papacci P, Romagnoli C. Lepore D, et al. Ophthalmology. 2014 Nov;121(11):2212-9. doi: 10.1016/j.ophtha.2014.05.015. Epub 2014 Jul 4. Ophthalmology. 2014. PMID: 25001158 Clinical Trial.
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9).
Yetik H. Yetik H. Ophthalmology. 2015 Aug;122(8):e49. doi: 10.1016/j.ophtha.2014.11.031. Ophthalmology. 2015. PMID: 26210602 No abstract available.